MLPFX
Price
$11.21
Change
+$0.01 (+0.09%)
Updated
Sep 11 closing price
Net Assets
2.46B
MLPNX
Price
$8.51
Change
+$0.01 (+0.12%)
Updated
Sep 11 closing price
Net Assets
353.57M
Interact to see
Advertisement

MLPFX vs MLPNX

MLPFX vs MLPNX Comparison Chart in %
View a ticker or compare two or three
VS
MLPFX vs. MLPNX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPFX is a Hold and MLPNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPFX has more cash in the bank: 2.46B vs. MLPNX (354M). MLPFX pays higher dividends than MLPNX: MLPFX (5.09) vs MLPNX (4.29). MLPFX was incepted earlier than MLPNX: MLPFX (16 years) vs MLPNX (15 years). MLPNX (3.49) is less costly to investors than MLPFX (1.45). MLPNX is a more actively managed with annual turnover of: 25.00 vs. MLPFX (14.00). MLPFX (1000) and MLPNX (1000) have matching initial minimum investment requirements. MLPNX annual gain was more profitable for investors over the last year : 42.03 vs. MLPFX (33.03). MLPNX return over 5 years is better than : 297.62 vs. MLPFX (190.95).
MLPFXMLPNXMLPFX / MLPNX
Total Expense Ratio1.443.4941%
Annual Report Gross Expense Ratio1.453.4942%
Fund Existence16 years15 years-
Gain YTD29.60739.14476%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.46B354M696%
Annual Yield % from dividends5.094.29119%
Returns for 1 year33.0342.0379%
Returns for 3 years97.22129.9775%
Returns for 5 years190.95297.6264%
Returns for 10 years169.23181.2093%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKK83.580.52
+0.63%
ARK Innovation ETF
BAMO34.820.20
+0.59%
Brookstone Opportunities ETF
AVK12.230.07
+0.58%
Advent Convertible and Income Fund
AVMU43.780.16
+0.37%
Avantis Core Municipal Fixed Inc ETF
THNR25.59-0.41
-1.59%
Amplify Weight Loss Drug & Treatment ETF